Editorial - Journal of Gastroenterology and Digestive Diseases (2021) Volume 6, Issue 2
Brief Note On an Oral antibiotic within the treatment of primary sclerosing cholangitis-associated pouchitis
The combination of atezolizumab and bevacizumab showed encouraging anticancer activity and safety in a very section 1b trial involving patients with unresectable hepatoma.Pouchitis may be a common complication in those with restorative proctocolectomy with ileal pouch?anal conjugation (IPAA). Some patients might develop chronic antibiotic-refractory pouchitis and its management is difficult. Primary sclerosing rubor (PSC) has systematically been rumored to be a risk issue for chronic pouchitis.